New FDA guidance on promotions

Alexander Gaffney from raps.org has published an article on the newly released FDA guidance Distributing Scientific and Medical Publications on Unapproved New Uses — Recommended Practices addressing how companies can use scientific literature to promote its products....

Middle market transactions the new trend?

Deanna Pogorelc from medcitynews.com wrote an interesting article on the impact middle market pharma companies are having on mergers and acquisitions in the pharmaceutical industry. PwC reported in their yearend report on the industry that 2013 was up 46% in...

Pharma mergers and acquisition on the move

Kevin Mccaffery from mmm-online.com brings to light a very interesting topic on mergers and acquisitions (M&A) in the pharmaceutical industry. In the article, Mccaffery reviews the big slump in M&A activity with 2012 being the worst in recent history. While it...